⌕
Edwards Lifesciences · EW · NYSE
Tenet 57 · Mixed
Compare
$107.15+1.28%At closeTenet 57 · Mixed
$107.15+1.35 (+1.28%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD

Edwards Lifesciences (EW) Stock

Edwards Lifesciences (EW) closed at $107.15 on Nov 13, 2026; its Tenet Score is 57 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$107.15
Nov 13, 2026
Market cap
$61.6B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
60.6×
price ÷ earnings
52-week range
74.66 – 107.69
low → high
Tenet Score
57/100
Mixed · 409 Healthcare peers

Industry: Health Services · see every company filed here →

Edwards Lifesciences Corp scores 57/100. Mixed. Strongest on quality and financial health, value is the soft spot, trading at 61× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
57/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
25
Quality
73
Health
73
Growth
55

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityBHealthBGrowthCMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
5.7×
price to book value
P/S
9.2×
price to fiscal 2025 sales
ROE
10%
return on equity
Operating margin
20.8%
fiscal 2025, before interest and tax
Net margin
15.2%
of revenue kept
Current ratio
4.60
current assets to liabilities
Net debt / EBITDA
−2.5×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products fo…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 320 US ETFs · top wrappers by weightSee all ETFs holding EW →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

CompanyTenet ScoreMarket cap
HCA Healthcare IncHCA54$104.2B
Elevance Health IncELV52$92.8B
Cigna Group (The)CI51$78.3B
Boston Scientific Corp.BSX61$64.3B
Becton Dickinson & Co.BDX46$59.4B
Humana Inc.HUM48$54.0B
Agilent Technologies Inc.A50$49.0B
Natera IncNTRA44$46.3B
Waters Corp.WAT44$45.2B
IQVIA Holdings IncIQV46$43.7B

Compare Edwards Lifesciences with

What sector and industry is Edwards Lifesciences in?

Edwards Lifesciences is in the Healthcare sector and the Health Services industry.

What is Edwards Lifesciences' Tenet Score?

Edwards Lifesciences' Tenet Score is 57 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.